Dynamic Capital Management Ltd purchased a new stake in shares of Qiagen N.V. (NASDAQ:QGEN) during the third quarter, according to its most recent 13F filing with the SEC. The firm purchased 92,852 shares of the company’s stock, valued at approximately $2,548,000.
A number of other hedge funds also recently bought and sold shares of the stock. Public Employees Retirement Association of Colorado boosted its stake in shares of Qiagen N.V. by 0.4% in the third quarter. Public Employees Retirement Association of Colorado now owns 7,356 shares of the company’s stock worth $202,000 after buying an additional 31 shares during the period. Amalgamated Bank boosted its stake in shares of Qiagen N.V. by 2.2% in the second quarter. Amalgamated Bank now owns 27,591 shares of the company’s stock worth $738,000 after buying an additional 598 shares during the period. BNP Paribas Arbitrage SA boosted its stake in shares of Qiagen N.V. by 3.8% in the third quarter. BNP Paribas Arbitrage SA now owns 26,293 shares of the company’s stock worth $721,000 after buying an additional 973 shares during the period. BlackRock Advisors LLC boosted its stake in shares of Qiagen N.V. by 1.6% in the third quarter. BlackRock Advisors LLC now owns 93,000 shares of the company’s stock worth $2,552,000 after buying an additional 1,438 shares during the period. Finally, Wells Fargo & Company MN boosted its stake in shares of Qiagen N.V. by 2.8% in the third quarter. Wells Fargo & Company MN now owns 55,405 shares of the company’s stock worth $1,520,000 after buying an additional 1,535 shares during the period. 60.27% of the stock is currently owned by hedge funds and other institutional investors.
Qiagen N.V. (NASDAQ:QGEN) opened at 29.12 on Friday. The company has a market cap of $6.58 billion, a price-to-earnings ratio of 83.44 and a beta of 1.05. The company has a 50-day moving average of $29.07 and a 200-day moving average of $28.13. Qiagen N.V. has a 12 month low of $20.73 and a 12 month high of $30.12.
Qiagen N.V. (NASDAQ:QGEN) last announced its quarterly earnings data on Wednesday, February 1st. The company reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.05. The business had revenue of $366.50 million for the quarter, compared to the consensus estimate of $372.70 million. Qiagen N.V. had a net margin of 5.85% and a return on equity of 10.01%. Qiagen N.V.’s quarterly revenue was up 5.2% on a year-over-year basis. During the same quarter last year, the company posted $0.31 earnings per share. Analysts predict that Qiagen N.V. will post $1.26 EPS for the current year.
COPYRIGHT VIOLATION WARNING: This piece of content was published by sleekmoney and is the property of of sleekmoney. If you are viewing this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright law. The correct version of this piece of content can be accessed at http://sleekmoney.com/92852-shares-in-qiagen-n-v-qgen-acquired-by-dynamic-capital-management-ltd/1655623.html.
QGEN has been the topic of a number of research reports. Commerzbank Ag reissued a “buy” rating on shares of Qiagen N.V. in a report on Wednesday, January 25th. Zacks Investment Research cut shares of Qiagen N.V. from a “buy” rating to a “hold” rating in a report on Wednesday, October 19th. Barclays PLC reissued a “buy” rating on shares of Qiagen N.V. in a report on Monday, January 9th. J P Morgan Chase & Co reissued a “hold” rating and set a $27.00 target price on shares of Qiagen N.V. in a report on Thursday, November 3rd. Finally, Jefferies Group LLC reissued a “hold” rating on shares of Qiagen N.V. in a report on Friday, February 3rd. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the company. Qiagen N.V. presently has a consensus rating of “Hold” and an average price target of $26.71.
Qiagen N.V. Company Profile
QIAGEN N.V. (QIAGEN) is a holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems.
Want to see what other hedge funds are holding QGEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Qiagen N.V. (NASDAQ:QGEN).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/92852-shares-in-qiagen-n-v-qgen-acquired-by-dynamic-capital-management-ltd/1655623.html
Receive News & Ratings for Qiagen N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qiagen N.V. and related companies with MarketBeat.com's FREE daily email newsletter.